Dopamine Hydrochloride Injection Shortage: Latest Availability and Manufacturer Updates

What’s in Shortage

Generic Name: Dopamine Hydrochloride Injection
Brand Name: DOPAMINE HYDROCHLORIDE AND DEXTROSE
Dosage Form: Injection
Therapeutic Category: Cardiovascular
Current Status: Current Shortage
Initial Posting Date: 11/06/2017
Last Updated: 02/02/2026

Dopamine Hydrochloride Injection is currently listed as being in shortage. This medication is primarily used within the cardiovascular therapeutic category.

Which Manufacturers Are Affected

According to the FDA database, the following manufacturer information is available:

Baxter Healthcare

• Status: Available
• Contact Info: 888-229-0001
• Available Presentations:
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)

Why There’s a Shortage

No specific reason for the shortage was provided in the source data at this time.

What Patients Should Do

If you are a patient or caregiver affected by this shortage, please take the following steps:

• Consult Your Healthcare Provider: Discuss your treatment plan and any concerns regarding medication availability with your doctor.
• Talk to Your Pharmacist: Pharmacists can provide the most current information regarding local stock and supply chain updates.
• Contact the Manufacturer: For specific questions regarding supply, you may contact Baxter Healthcare at 888-229-0001.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding their medications and treatment options.

Source

Attribution: FDA Drug Shortage Database